Researchers found a link between frailty and risk for infection following immunosuppression in patients with inflammatory bowel disease after adjusting for age and comorbidities.

“Since infections and infection-related hospitalizations are a leading cause of morbidity and mortality in patients with IBD and a significant cause for concern among patients, frailty should be more systematically and prospectively studied in patients with IBD,” Bharati Kochar, MD, MSCR, of the division of Gastroenterology at Massachusetts General Hospital, and colleagues wrote. “Furthermore,

Full Article: https://www.healio.com/gastroenterology/irritable-bowel-syndrome/news/online/72e33796-13a3-4cd5-b0a5-bc6f36af5a7d/frailty-linked-with-increased-infection-risk-after-immunosuppression-for-ibd